LeafNLP Demos
Back to explore

Report #2887435

Received Mar 3, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
Nov 5, 2025
Onset
Nov 21, 2025
Days to onset
16
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.1Z005718—
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.2Z005718—
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.UNK——
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.UNK——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No adverse effects reported; patient received early dose of MMR II. First dose was given on 11/5/2025 and second dose given on 11/21/2025.; This spontaneous report was received from an Office Manager and refers to a 15-month-old patient of unknown gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. On 05-Nov-2025 and 21-Nov-2025, the patient was vaccinated with the first and second doses (respectively) of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Solution for injection (Both doses with lot # Z005718 has been verified to be valid, expiration date: 07-Mar-2027) (route of administration and site of administration were not provided) which were reconstituted in sterile diluents (strength, route of administration, site of administration, lot #, and expiration date were not provided) as prophylaxis (Inappropriate schedule of product administration). Unclear if second dose was due to outbreak. No adverse effects reported.